| 标题 |
Atorvastatin safety and pharmacokinetics in acute kawasaki disease patients with coronary artery abnormalities
阿托伐他汀在急性川崎病冠状动脉异常患者中的安全性和药代动力学
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Introduction: Despite therapy with intravenous immunoglobulin, 25% of children with Kawasaki disease (KD) develop coronary artery abnormalities (CAA) and endothelial cell (EC) dysfunction. Based on the pleiotropic effects of statins on restoring EC homeostasis, we performed a Phase I clinical trial of atorvastatin for acute KD patients with early CAA. Hypothesis: A sixweek (wk) course of atorvastatin in acute KD patients (pts) with CAA will be safe, welltolerated and restore EC homeostasis. Methods: This twocenter, Phase I, open label, dose escalation trial enrolled acute KD subjects aged 217 years with an initial CA Z score ≥ 2.5 in a 6wk study of atorvastatin (0.125, 0.25, 0.5 and 0.75 mg/kg/day). Demographic, clinical and laboratory data, and echo core lab readings were collected at baseline, |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
浮游
鸣笛
馆长
不想干活
LMW
Maestro_S
leaolf
个性的紫菜
小青椒
Dean
小明
带头大哥
昏睡的蟠桃
linkman
生动梦松
不配.
Kirito
不安青牛
TNT
一叶知秋
皖公网安备34019202002308
